KMT2A and acute myeloid leukemia: To determine whether the methyltransferase activity of SETDB1 is necessary for the reduction of Meis1 and Hoxa9 expression, we generated MLL-AF9 AML cell lines expressing the catalytic dead SETDB1_C1226A (SETDB1_CD) (Figure 3G) [56].